Eskitis Institute for Cell and Molecular Therapies

Eskitis Institute for Cell and Molecular Therapies building N75

Eskitis 2 building, opened April 2008

The Eskitis Institute for Cell and Molecular Therapies investigates novel drug- and cell-based therapies for human diseases in the thematic areas of:

  • Cancer
  • Infection and immunity
  • Neglected diseases
  • Neurodegenerative diseases
  • Stem cell biology

These themes were chosen on the basis of the Eskitis Institutes existing expertise and facilities, the importance of the therapeutic area and the potential for future discoveries. The Institute works towards the development of new strategies to prevent and treat diseases, with an emphasis on multi-disciplinary research and collaboration within the Institute and with national and international partners.

Located in the Brisbane Innovation Park adjacent to Griffith University's Nathan Campus (Map PDF 740KB), Eskitis is equipped with industry standard equipment and facilities to speed the development of new strategies to prevent and/or treat these diseases.

Collaborating Partners

BioCel interior of the Queensland Compound Library

Eskitis incorporates

National Centre for Adult Stem Cell Research

Investigating the biology of adult stem cells in cell transplantation therapies, disease biology and drug discovery

Queensland Compound Library

Australia's only dedicated compound management and logistics facility

Cancer Therapeutics Cooperative Research Centre

Node of the Cancer Therapeutics CRC - bridging the gap between cutting edge cancer biology and new drugs for the treatment of cancer

Partners

Pfizer
Innate pharmaceticals
Medicines for Malaria Venture
Drugs for Neglected Diseases Inititive

Back to top

Member of Innovative Research Universities Australia